메뉴 건너뛰기




Volumn 90, Issue 19, 1998, Pages 1461-1467

Biologic activity of tamoxifen at low doses in healthy women

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; CHOLESTEROL; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; SOMATOMEDIN C; TAMOXIFEN;

EID: 0032494478     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.19.1461     Document Type: Article
Times cited : (96)

References (60)
  • 1
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomized trials
    • Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451-67.
    • (1998) Lancet , vol.351 , pp. 1451-1467
  • 2
    • 0030941236 scopus 로고    scopus 로고
    • Tamoxifen: The herald of a new era of preventive therapeutics
    • Jordan VC. Tamoxifen: the herald of a new era of preventive therapeutics. J Natl Cancer Inst 1997;89:747-9.
    • (1997) J Natl Cancer Inst , vol.89 , pp. 747-749
    • Jordan, V.C.1
  • 3
    • 0032490068 scopus 로고    scopus 로고
    • Breast cancer prevention trial shows major benefit, some risk
    • Smigel K. Breast cancer prevention trial shows major benefit, some risk. J Natl Cancer Inst 1998;90:647-8.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 647-648
    • Smigel, K.1
  • 4
    • 0028208456 scopus 로고
    • Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
    • Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-37.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 527-537
    • Fisher, B.1    Costantino, J.P.2    Redmond, C.K.3    Fisher, E.R.4    Wickerham, D.L.5    Cronin, W.M.6
  • 5
    • 0028898873 scopus 로고
    • Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies
    • Stockholm Breast Cancer Study Group
    • Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1995;87:645-51.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 645-651
    • Rutqvist, L.E.1    Johansson, H.2    Signomklao, T.3    Johansson, U.4    Fornander, T.5    Wilking, N.6
  • 7
    • 0027787754 scopus 로고
    • Pharmacokinetics of anti-endocrine agents
    • Lonning PE, Lien EA. Pharmacokinetics of anti-endocrine agents. Cancer Sury 1993;17: 343-70.
    • (1993) Cancer Sury , vol.17 , pp. 343-370
    • Lonning, P.E.1    Lien, E.A.2
  • 8
    • 0020003085 scopus 로고
    • Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth
    • Coezy E, Borgna JL, Rochefort H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982;42: 317-23.
    • (1982) Cancer Res , vol.42 , pp. 317-323
    • Coezy, E.1    Borgna, J.L.2    Rochefort, H.3
  • 9
    • 0023621378 scopus 로고
    • Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells
    • Sutherland RL, Watts CK, Hall RE, Ruenitz PC. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. J Steroid Biochem 1987;27:891-7.
    • (1987) J Steroid Biochem , vol.27 , pp. 891-897
    • Sutherland, R.L.1    Watts, C.K.2    Hall, R.E.3    Ruenitz, P.C.4
  • 10
    • 0028000253 scopus 로고
    • Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment
    • Love RR, Wiebe DA, Feyzi JM, Newcomb PA, Chappell RJ. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment. J Natl Cancer Inst 1994;86:1534-9.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1534-1539
    • Love, R.R.1    Wiebe, D.A.2    Feyzi, J.M.3    Newcomb, P.A.4    Chappell, R.J.5
  • 12
    • 0026519891 scopus 로고
    • Antithrombin III level, fibrinogen level and platelet count changes with adjuvant tamoxifen therapy
    • Love RR, Surawicz TS, Williams EC. Antithrombin III level, fibrinogen level and platelet count changes with adjuvant tamoxifen therapy. Arch Intern Med 1992;152:317-20.
    • (1992) Arch Intern Med , vol.152 , pp. 317-320
    • Love, R.R.1    Surawicz, T.S.2    Williams, E.C.3
  • 14
    • 0024539364 scopus 로고
    • Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer
    • Coletti RB, Roberts JD, Devlin JT, Copeland KC. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 1989;49:1882-4.
    • (1989) Cancer Res , vol.49 , pp. 1882-1884
    • Coletti, R.B.1    Roberts, J.D.2    Devlin, J.T.3    Copeland, K.C.4
  • 16
    • 0032508293 scopus 로고    scopus 로고
    • Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
    • Italian Tamoxifen Prevention Study
    • Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 1998;352:93-7.
    • (1998) Lancet , vol.352 , pp. 93-97
    • Veronesi, U.1    Maisonneuve, P.2    Costa, A.3    Sacchini, V.4    Maltoni, C.5    Robertson, C.6
  • 17
    • 0022908915 scopus 로고
    • Stability of total cholesterol, high-density-lipoprotein cholesterol, and triglycerides in frozen sera
    • Stokes YM, Salmond CE, Carpenter LM, Weby TJ. Stability of total cholesterol, high-density-lipoprotein cholesterol, and triglycerides in frozen sera. Clin Chem 1986;32:995-9.
    • (1986) Clin Chem , vol.32 , pp. 995-999
    • Stokes, Y.M.1    Salmond, C.E.2    Carpenter, L.M.3    Weby, T.J.4
  • 18
    • 17344377231 scopus 로고    scopus 로고
    • WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser 1996;863:1-194.
    • (1996) World Health Organ Tech Rep Ser , vol.863 , pp. 1-194
  • 19
    • 0027948506 scopus 로고
    • A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women
    • The Framingham Heart Study
    • Bostom AG, Gagnon DR, Cupples LA, Wilson PW, Jenner JL, Ordovas JM, et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994;90:1688-95.
    • (1994) Circulation , vol.90 , pp. 1688-1695
    • Bostom, A.G.1    Gagnon, D.R.2    Cupples, L.A.3    Wilson, P.W.4    Jenner, J.L.5    Ordovas, J.M.6
  • 21
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 22
    • 0028031664 scopus 로고
    • Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
    • Garnero P, Grimaux M, Seguin P, Dehnas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64.
    • (1994) J Bone Miner Res , vol.9 , pp. 255-264
    • Garnero, P.1    Grimaux, M.2    Seguin, P.3    Dehnas, P.D.4
  • 23
    • 0018959529 scopus 로고
    • Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
    • Daughaday WH, Mariz IK, Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 1980;51:781-8.
    • (1980) J Clin Endocrinol Metab , vol.51 , pp. 781-788
    • Daughaday, W.H.1    Mariz, I.K.2    Blethen, S.L.3
  • 24
    • 0025689891 scopus 로고
    • An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence
    • Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 1990;82:1916-24.
    • (1990) Circulation , vol.82 , pp. 1916-1924
    • Holme, I.1
  • 25
    • 0027249160 scopus 로고
    • Tamoxifen-induced decrease in total cholesterol with 2 weeks of treatment
    • Love RR, Mamby CC, Feyzi JM. Tamoxifen-induced decrease in total cholesterol with 2 weeks of treatment. J Natl Cancer Inst 1993; 85:1344-5.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 1344-1345
    • Love, R.R.1    Mamby, C.C.2    Feyzi, J.M.3
  • 26
    • 0026472377 scopus 로고
    • Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development
    • Ruan W, Newman CB, Kleinberg DL. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci U S A 1992;89:10872-6.
    • (1992) Proc Natl Acad Sci U S A , vol.89 , pp. 10872-10876
    • Ruan, W.1    Newman, C.B.2    Kleinberg, D.L.3
  • 28
    • 0024460381 scopus 로고
    • Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice
    • Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, et al. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 1989;84:1418-23.
    • (1989) J Clin Invest , vol.84 , pp. 1418-1423
    • Arteaga, C.L.1    Kitten, L.J.2    Coronado, E.B.3    Jacobs, S.4    Kull Jr., F.C.5    Allred, D.C.6
  • 30
    • 0029129747 scopus 로고
    • Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer
    • Bruning PF, Van Doom J, Bonfrer JM, Van Noord PA, Korse CM, Linders TC, et al. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 1995;62:266-70.
    • (1995) Int J Cancer , vol.62 , pp. 266-270
    • Bruning, P.F.1    Van Doom, J.2    Bonfrer, J.M.3    Van Noord, P.A.4    Korse, C.M.5    Linders, T.C.6
  • 35
    • 0000147542 scopus 로고    scopus 로고
    • Recent advances in chemoprevention of cancer
    • Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278: 1073-7.
    • (1997) Science , vol.278 , pp. 1073-1077
    • Hong, W.K.1    Sporn, M.B.2
  • 36
    • 0030899189 scopus 로고    scopus 로고
    • Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus
    • Li D, Dragan Y, Jordan VC, Wang M, Pitot HC. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Cancer Res 1997; 57:1438-41.
    • (1997) Cancer Res , vol.57 , pp. 1438-1441
    • Li, D.1    Dragan, Y.2    Jordan, V.C.3    Wang, M.4    Pitot, H.C.5
  • 37
    • 0029745072 scopus 로고    scopus 로고
    • Tamoxifcn-induced DNA adducts in endometrial samples from breast cancer patients
    • Hemminki K, Rajaniemi H, Lindhal B, Moberger B. Tamoxifcn-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res 1996;56:4374-7.
    • (1996) Cancer Res , vol.56 , pp. 4374-4377
    • Hemminki, K.1    Rajaniemi, H.2    Lindhal, B.3    Moberger, B.4
  • 39
    • 0027994593 scopus 로고
    • Established risk factors and coronary artery disease: The Framingham Study
    • Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens 1994;7:7S-12S.
    • (1994) Am J Hypertens , vol.7
    • Wilson, P.W.1
  • 40
    • 0025812175 scopus 로고
    • Blood platelet count and function are related to total and cardiovascular death in apparently healthy men
    • Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84: 613-7.
    • (1991) Circulation , vol.84 , pp. 613-617
    • Thaulow, E.1    Erikssen, J.2    Sandvik, L.3    Stormorken, H.4    Cohn, P.F.5
  • 41
    • 0027479505 scopus 로고
    • White blood cell count, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study
    • Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1993;125:855-63.
    • (1993) Am Heart J , vol.125 , pp. 855-863
    • Gillum, R.F.1    Ingram, D.D.2    Makuc, D.M.3
  • 42
    • 0032503554 scopus 로고    scopus 로고
    • Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients
    • Torrisi R, Parodi S, Fontana V, Pensa F, Casella C, Barreca A, et al. Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients. Int J Cancer 1998;76:787-90.
    • (1998) Int J Cancer , vol.76 , pp. 787-790
    • Torrisi, R.1    Parodi, S.2    Fontana, V.3    Pensa, F.4    Casella, C.5    Barreca, A.6
  • 43
    • 8244264298 scopus 로고    scopus 로고
    • Hypocholesterolemic activity of raloxifene (LY139481): Pharmacological characterization as a selective estrogen receptor modulator
    • Kauffman RF, Bensch WR, Roudebush RE, Cole HW, Bean JS, Phillips DL, et al. Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator. J Pharmacol Exp Ther 1997;280:146-53.
    • (1997) J Pharmacol Exp Ther , vol.280 , pp. 146-153
    • Kauffman, R.F.1    Bensch, W.R.2    Roudebush, R.E.3    Cole, H.W.4    Bean, J.S.5    Phillips, D.L.6
  • 45
    • 0029038734 scopus 로고
    • Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor
    • Blobel GA, Sieff CA, Orkin SH, Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 1995;15:3147-53.
    • (1995) Mol Cell Biol , vol.15 , pp. 3147-3153
    • Blobel, G.A.1    Sieff, C.A.2    Orkin, S.H.3
  • 46
    • 0028342854 scopus 로고
    • The estrogen receptor is present in human megakaryocytes
    • Tarantino MD, Kunicki TJ, Nugent DJ. The estrogen receptor is present in human megakaryocytes. Ann N Y Acad Sci 1994;714: 293-6.
    • (1994) Ann N Y Acad Sci , vol.714 , pp. 293-296
    • Tarantino, M.D.1    Kunicki, T.J.2    Nugent, D.J.3
  • 47
    • 0028803064 scopus 로고
    • Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes
    • Ben-Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y, Sharp A, et al. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol 1995;34:363-9.
    • (1995) Am J Reprod Immunol , vol.34 , pp. 363-369
    • Ben-Hur, H.1    Mor, G.2    Insler, V.3    Blickstein, I.4    Amir-Zaltsman, Y.5    Sharp, A.6
  • 48
    • 0028286272 scopus 로고
    • Estrogen regulation of the insulin-like growth factor 1 gene transcription involves an AP-1 enhancer
    • Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, et al. Estrogen regulation of the insulin-like growth factor 1 gene transcription involves an AP-1 enhancer. J Biol Chem 1994;269:16433-42.
    • (1994) J Biol Chem , vol.269 , pp. 16433-16442
    • Umayahara, Y.1    Kawamori, R.2    Watada, H.3    Imano, E.4    Iwama, N.5    Morishima, T.6
  • 50
    • 0029451354 scopus 로고
    • Tamoxifen's role in chemoprevention of breast cancer: An update
    • Nayfield SG. Tamoxifen's role in chemoprevention of breast cancer: an update. J Cell Biochem Suppl 1995;22:42-50.
    • (1995) J Cell Biochem Suppl , vol.22 , pp. 42-50
    • Nayfield, S.G.1
  • 51
    • 3543123425 scopus 로고
    • Tamoxifen used as a chemopreventative agent lowers serum IGF-I levels
    • Pollak M, Powles TJ, Baum M, Sacks N. Tamoxifen used as a chemopreventative agent lowers serum IGF-I levels [abstract]. Proc Am Assoc Cancer Res 1993;34:255.
    • (1993) Proc Am Assoc Cancer Res , vol.34 , pp. 255
    • Pollak, M.1    Powles, T.J.2    Baum, M.3    Sacks, N.4
  • 52
    • 0027229625 scopus 로고
    • Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy
    • Friedl A, Jordan VC, Pollak M. Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy. Eur J Cancer 1993;29A:1368-72.
    • (1993) Eur J Cancer , vol.29 A , pp. 1368-1372
    • Friedl, A.1    Jordan, V.C.2    Pollak, M.3
  • 53
    • 0002997892 scopus 로고    scopus 로고
    • Experimental results on the chemopreventive and side effects of tamoxifen using a human-equivalent animal model
    • Maltoni C, Soffritti M, Davis W, editors. Amsterdam: Elsevier Sciences
    • Maltoni C, Minardi F, Belpoggi F, Pinto C, Lenzi A, Filippini F. Experimental results on the chemopreventive and side effects of tamoxifen using a human-equivalent animal model. In: Maltoni C, Soffritti M, Davis W, editors. The scientific bases of cancer chemoprevention. Amsterdam: Elsevier Sciences; 1996. p. 197-217.
    • (1996) The Scientific Bases of Cancer Chemoprevention , pp. 197-217
    • Maltoni, C.1    Minardi, F.2    Belpoggi, F.3    Pinto, C.4    Lenzi, A.5    Filippini, F.6
  • 54
    • 0029994748 scopus 로고    scopus 로고
    • Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats
    • Sato M, Rippy MK, Bryant HU. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J 1996;10: 905-12.
    • (1996) FASEB J , vol.10 , pp. 905-912
    • Sato, M.1    Rippy, M.K.2    Bryant, H.U.3
  • 55
    • 0031013929 scopus 로고    scopus 로고
    • Comparative effects of droloxifene, tamoxifen and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model
    • Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, et al. Comparative effects of droloxifene, tamoxifen and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 1997; 20:31-9.
    • (1997) Bone , vol.20 , pp. 31-39
    • Ke, H.Z.1    Chen, H.K.2    Simmons, H.A.3    Qi, H.4    Crawford, D.T.5    Pirie, C.M.6
  • 56
    • 0025936010 scopus 로고
    • Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent
    • Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 1991;83:1488-91.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 1488-1491
    • Jordan, V.C.1    Fritz, N.F.2    Langan-Fahey, S.3    Thompson, M.4    Tormey, D.C.5
  • 57
    • 0024506261 scopus 로고
    • A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive -mors
    • Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive -mors. N Engl J Med 1989;320:479-84.
    • (1989) N Engl J Med , vol.320 , pp. 479-484
    • Fisher, B.1    Costantino, J.2    Redmond, C.3    Poisson, R.4    Bowman, D.5    Couture, J.6
  • 58
    • 0025996176 scopus 로고
    • Symptoms associated with tamoxifen treatment in postmenopausal women
    • Love RR, Cameron L, Connell BL, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991;151:1842-7.
    • (1991) Arch Intern Med , vol.151 , pp. 1842-1847
    • Love, R.R.1    Cameron, L.2    Connell, B.L.3    Leventhal, H.4
  • 59
    • 0030664688 scopus 로고    scopus 로고
    • Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
    • Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641-7 [see comments in: Fileihan GE. Tissue-specific estrogens - the promise for the future. N Engl J Med 1997;337: 1686-7].
    • (1997) N Engl J Med , vol.337 , pp. 1641-1647
    • Delmas, P.D.1    Bjarnason, N.H.2    Mitlak, B.H.3    Ravoux, A.C.4    Shah, A.S.5    Huster, W.J.6
  • 60
    • 0030685047 scopus 로고    scopus 로고
    • Tissue-specific estrogens - The promise for the future
    • Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641-7 [see comments in: Fileihan GE. Tissue-specific estrogens - the promise for the future. N Engl J Med 1997;337: 1686-7].
    • (1997) N Engl J Med , vol.337 , pp. 1686-1687
    • Fileihan, G.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.